Juno Nears Biggest Biotech Mark With $153M IPO Plan
Juno Therapeutics Inc. fine-tuned its initial public offering Tuesday, setting terms for a $153 million float that would make it the largest biotech of 2014 by diluted market capitalization, as fellow...To view the full article, register now.
Already a subscriber? Click here to view full article